Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001096906-23-001823
Filing Date
2023-09-21
Accepted
2023-09-21 11:07:21
Documents
1
Period of Report
2023-09-21

Document Format Files

Seq Description Document Type Size
1 AXIM BIOTECHNOLOGIES, INC. - DEF14C axim_def14c.htm DEF 14C 90047
  Complete submission text file 0001096906-23-001823.txt   91191
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

EIN.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-54296 | Film No.: 231268235
SIC: 2834 Pharmaceutical Preparations